07:34 EST Exact Sciences (EXAS) jumps 17% to $100.98 after Abbott (ABT) buyout offer
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Mizuho says $100 per share takeout price for Exact Sciences ‘feasible’
- BofA moves to No Rating on Exact Sciences after Abbott report
- Buy Rating Maintained Amid Speculation of Abbott’s Strategic Acquisition of Exact Sciences
- Buy Rating for Exact Sciences Amid Potential Abbott Labs Acquisition and Growth Prospects
- Strategic Acquisition Potential: Abbott’s Interest in Exact Sciences Enhances Investment Appeal